ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.45
+3.57%Leverage
- Debt / equity
- 0.30x
- Net debt / equity
- 0.10x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -1.29x
- Net debt / EBITDA
- -0.43x
Liquidity & coverage
- Current ratio
- 1.14x
- Quick ratio
- 0.82x
- Cash ratio
- 0.43x
- Interest coverage
- -21.71x
- EBITDA / interest
- -13.91x
- Working capital
- $2.5M
Cash & dividend
- FCF / debt
- 0.33x
- Cash flow / debt
- 0.26x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025